DDrare: Database of Drug Development for Rare Diseases

Target Gene/Pathway（薬物標的遺伝子／パスウェイリスト）💬 Info on mouse-over

A B C D E F G H I J K L M N O PQR S T U V WXYZother

146 / 286 pathways

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	指定難病告示番号
1	Acute myeloid leukemia 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
2	Acute myeloid leukemia 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
3	Adherens junction 💬	2件: EGFR, ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
4	Adherens junction 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
5	Adipocytokine signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
6	Adipocytokine signaling pathway 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
7	Adipocytokine signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
8	Adipocytokine signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
9	Adrenergic signaling in cardiomyocytes 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	D00608 💬	Doxazosin	2件: 57, 67 💬
10	Adrenergic signaling in cardiomyocytes 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	D07874 💬	Doxazosin	2件: 57, 67 💬
11	Adrenergic signaling in cardiomyocytes 💬	1件: ADRB1 💬	D00634 💬	Bisoprolol	3件: 67, 86, 113 💬
12	Adrenergic signaling in cardiomyocytes 💬	1件: ADRB1 💬	D02342 💬	Bisoprolol	3件: 67, 86, 113 💬
13	Adrenergic signaling in cardiomyocytes 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
14	Adrenergic signaling in cardiomyocytes 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
15	Adrenergic signaling in cardiomyocytes 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
16	Adrenergic signaling in cardiomyocytes 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
17	Adrenergic signaling in cardiomyocytes 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
18	Adrenergic signaling in cardiomyocytes 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
19	Adrenergic signaling in cardiomyocytes 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
20	Adrenergic signaling in cardiomyocytes 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
21	Adrenergic signaling in cardiomyocytes 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
22	Adrenergic signaling in cardiomyocytes 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
23	AGE-RAGE signaling pathway in diabetic complications 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
24	AGE-RAGE signaling pathway in diabetic complications 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
25	AGE-RAGE signaling pathway in diabetic complications 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
26	AGE-RAGE signaling pathway in diabetic complications 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
27	AGE-RAGE signaling pathway in diabetic complications 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
28	AGE-RAGE signaling pathway in diabetic complications 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
29	Aldosterone synthesis and secretion 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
30	Aldosterone synthesis and secretion 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
31	Aldosterone synthesis and secretion 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
32	Aldosterone synthesis and secretion 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
33	Aldosterone synthesis and secretion 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
34	Aldosterone synthesis and secretion 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
35	Aldosterone synthesis and secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
36	Aldosterone synthesis and secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
37	Aldosterone synthesis and secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
38	Aldosterone synthesis and secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
39	Aldosterone-regulated sodium reabsorption 💬	1件: NR3C2 💬	D00443 💬	Spironolactone	7件: 58, 67, 86, 113, 210, 218, 225 💬
40	Alzheimer disease 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
41	Alzheimer disease 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
42	Alzheimer disease 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
43	Alzheimer disease 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
44	Alzheimer disease 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
45	Alzheimer disease 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
46	Amphetamine addiction 💬	2件: CACNA1C, CACNA1D 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
47	Amphetamine addiction 💬	2件: CACNA1C, CACNA1D 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
48	Amphetamine addiction 💬	2件: CACNA1C, CACNA1D 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
49	Amphetamine addiction 💬	2件: CACNA1C, CACNA1D 💬	D01173 💬	Cilnidipine	1件: 67 💬
50	AMPK signaling pathway 💬	1件: ADRA1A 💬	D00608 💬	Doxazosin	2件: 57, 67 💬
51	AMPK signaling pathway 💬	1件: ADRA1A 💬	D07874 💬	Doxazosin	2件: 57, 67 💬
52	AMPK signaling pathway 💬	1件: HMGCR 💬	D00893 💬	Pravastatin	9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
53	AMPK signaling pathway 💬	1件: HMGCR 💬	D08410 💬	Pravastatin	9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
54	AMPK signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
55	AMPK signaling pathway 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
56	AMPK signaling pathway 💬	1件: PPARG 💬	D00945 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
57	AMPK signaling pathway 💬	1件: PPARG 💬	D08378 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
58	AMPK signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
59	AMPK signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
60	Amyotrophic lateral sclerosis 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
61	Amyotrophic lateral sclerosis 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
62	Apelin signaling pathway 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
63	Apelin signaling pathway 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
64	Apelin signaling pathway 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
65	Apelin signaling pathway 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
66	Apelin signaling pathway 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
67	Apelin signaling pathway 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
68	Apelin signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
69	Apelin signaling pathway 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
70	Apelin signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
71	Apelin signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
72	Arrhythmogenic right ventricular cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
73	Arrhythmogenic right ventricular cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
74	Arrhythmogenic right ventricular cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
75	Arrhythmogenic right ventricular cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
76	Autophagy - animal 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
77	Autophagy - animal 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
78	Autophagy - animal 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
79	Autophagy - animal 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
80	Autophagy - other 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
81	Autophagy - other 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
82	Axon guidance 💬	2件: ABL1, SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
83	Axon guidance 💬	1件: EPHB4 💬	D11772 💬	Tesevatinib	1件: 67 💬
84	Bacterial invasion of epithelial cells 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
85	beta-Alanine metabolism 💬	1件: AOC3 💬	D08044 💬	Hydralazine	1件: 67 💬
86	Bile secretion 💬	1件: HMGCR 💬	D00893 💬	Pravastatin	9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
87	Bile secretion 💬	1件: HMGCR 💬	D08410 💬	Pravastatin	9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
88	Bile secretion 💬	1件: NR1H4 💬	D00734 💬	Ursodeoxycholic acid	13件: 6 , 8 , 20, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 💬
89	Bladder cancer 💬	2件: EGFR, ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
90	Bladder cancer 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
91	Breast cancer 💬	3件: EGFR, ERBB2, FLT4 💬	D11772 💬	Tesevatinib	1件: 67 💬
92	Breast cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
93	Breast cancer 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
94	C-type lectin receptor signaling pathway 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
95	Calcium signaling pathway 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	D00608 💬	Doxazosin	2件: 57, 67 💬
96	Calcium signaling pathway 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	D07874 💬	Doxazosin	2件: 57, 67 💬
97	Calcium signaling pathway 💬	1件: ADRB1 💬	D00634 💬	Bisoprolol	3件: 67, 86, 113 💬
98	Calcium signaling pathway 💬	1件: ADRB1 💬	D02342 💬	Bisoprolol	3件: 67, 86, 113 💬
99	Calcium signaling pathway 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
100	Calcium signaling pathway 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
101	Calcium signaling pathway 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
102	Calcium signaling pathway 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
103	Calcium signaling pathway 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
104	Calcium signaling pathway 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
105	Calcium signaling pathway 💬	5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
106	Calcium signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
107	Calcium signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
108	Calcium signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
109	Calcium signaling pathway 💬	4件: EGFR, ERBB2, FLT4, KDR 💬	D11772 💬	Tesevatinib	1件: 67 💬
110	cAMP signaling pathway 💬	1件: ADRB1 💬	D00634 💬	Bisoprolol	3件: 67, 86, 113 💬
111	cAMP signaling pathway 💬	1件: ADRB1 💬	D02342 💬	Bisoprolol	3件: 67, 86, 113 💬
112	cAMP signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
113	cAMP signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
114	cAMP signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
115	cAMP signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
116	cAMP signaling pathway 💬	3件: SSTR1, SSTR2, SSTR5 💬	D10147 💬	Pasireotide	3件: 67, 74, 75 💬
117	cAMP signaling pathway 💬	3件: SSTR1, SSTR2, SSTR5 💬	D07431 💬	Somatostatin	2件: 67, 78 💬
118	cAMP signaling pathway 💬	1件: SSTR2 💬	D00442 💬	Octreotide	7件: 67, 75, 84, 85, 89, 193, 227 💬
119	cAMP signaling pathway 💬	1件: SSTR2 💬	D06495 💬	Octreotide	7件: 67, 75, 84, 85, 89, 193, 227 💬
120	Carbohydrate digestion and absorption 💬	1件: CACNA1D 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
121	Carbohydrate digestion and absorption 💬	1件: CACNA1D 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
122	Carbohydrate digestion and absorption 💬	1件: CACNA1D 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
123	Carbohydrate digestion and absorption 💬	1件: CACNA1D 💬	D01173 💬	Cilnidipine	1件: 67 💬
124	Carbohydrate digestion and absorption 💬	2件: TAS1R2, TAS1R3 💬	D02381 💬	Aspartame	5件: 6 , 13, 67, 86, 230 💬
125	Cardiac muscle contraction 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
126	Cardiac muscle contraction 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
127	Cardiac muscle contraction 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
128	Cardiac muscle contraction 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
129	Cell cycle 💬	1件: ABL1 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
130	Cellular senescence 💬	1件: CACNA1D 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
131	Cellular senescence 💬	1件: CACNA1D 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
132	Cellular senescence 💬	1件: CACNA1D 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
133	Cellular senescence 💬	1件: CACNA1D 💬	D01173 💬	Cilnidipine	1件: 67 💬
134	Cellular senescence 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
135	Cellular senescence 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
136	Central carbon metabolism in cancer 💬	2件: EGFR, ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
137	Central carbon metabolism in cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
138	Central carbon metabolism in cancer 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
139	cGMP-PKG signaling pathway 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	D00608 💬	Doxazosin	2件: 57, 67 💬
140	cGMP-PKG signaling pathway 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	D07874 💬	Doxazosin	2件: 57, 67 💬
141	cGMP-PKG signaling pathway 💬	1件: ADRB1 💬	D00634 💬	Bisoprolol	3件: 67, 86, 113 💬
142	cGMP-PKG signaling pathway 💬	1件: ADRB1 💬	D02342 💬	Bisoprolol	3件: 67, 86, 113 💬
143	cGMP-PKG signaling pathway 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
144	cGMP-PKG signaling pathway 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
145	cGMP-PKG signaling pathway 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
146	cGMP-PKG signaling pathway 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
147	cGMP-PKG signaling pathway 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
148	cGMP-PKG signaling pathway 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
149	cGMP-PKG signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
150	cGMP-PKG signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
151	cGMP-PKG signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
152	cGMP-PKG signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
153	Chagas disease 💬	1件: ACE 💬	D08068 💬	Imidapril	1件: 67 💬
154	Chagas disease 💬	1件: ACE 💬	D00362 💬	Lisinopril	7件: 19, 46, 49, 66, 67, 113, 222 💬
155	Chagas disease 💬	1件: ACE 💬	D08131 💬	Lisinopril	7件: 19, 46, 49, 66, 67, 113, 222 💬
156	Chagas disease 💬	1件: ACE 💬	D00421 💬	Ramipril	7件: 46, 49, 66, 67, 113, 218, 257 💬
157	Chemokine signaling pathway 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
158	Choline metabolism in cancer 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
159	Choline metabolism in cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
160	Choline metabolism in cancer 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
161	Cholinergic synapse 💬	5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
162	Cholinergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
163	Cholinergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
164	Cholinergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
165	Chronic myeloid leukemia 💬	1件: ABL1 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
166	Circadian entrainment 💬	2件: CACNA1C, CACNA1D 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
167	Circadian entrainment 💬	2件: CACNA1C, CACNA1D 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
168	Circadian entrainment 💬	2件: CACNA1C, CACNA1D 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
169	Circadian entrainment 💬	2件: CACNA1C, CACNA1D 💬	D01173 💬	Cilnidipine	1件: 67 💬
170	Circadian rhythm 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
171	Circadian rhythm 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
172	Colorectal cancer 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
173	Colorectal cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
174	Colorectal cancer 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
175	Coronavirus disease - COVID-19 💬	1件: ACE 💬	D08068 💬	Imidapril	1件: 67 💬
176	Coronavirus disease - COVID-19 💬	1件: ACE 💬	D00362 💬	Lisinopril	7件: 19, 46, 49, 66, 67, 113, 222 💬
177	Coronavirus disease - COVID-19 💬	1件: ACE 💬	D08131 💬	Lisinopril	7件: 19, 46, 49, 66, 67, 113, 222 💬
178	Coronavirus disease - COVID-19 💬	1件: ACE 💬	D00421 💬	Ramipril	7件: 46, 49, 66, 67, 113, 218, 257 💬
179	Coronavirus disease - COVID-19 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
180	Coronavirus disease - COVID-19 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
181	Coronavirus disease - COVID-19 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
182	Coronavirus disease - COVID-19 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
183	Coronavirus disease - COVID-19 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
184	Coronavirus disease - COVID-19 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
185	Coronavirus disease - COVID-19 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
186	Cortisol synthesis and secretion 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
187	Cortisol synthesis and secretion 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
188	Cortisol synthesis and secretion 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
189	Cortisol synthesis and secretion 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
190	Cortisol synthesis and secretion 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
191	Cortisol synthesis and secretion 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
192	Cortisol synthesis and secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
193	Cortisol synthesis and secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
194	Cortisol synthesis and secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
195	Cortisol synthesis and secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
196	Cushing syndrome 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
197	Cushing syndrome 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
198	Cushing syndrome 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
199	Cushing syndrome 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
200	Cushing syndrome 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
201	Cushing syndrome 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
202	Cushing syndrome 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
203	Cushing syndrome 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
204	Cushing syndrome 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
205	Cushing syndrome 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
206	Cushing syndrome 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
207	Diabetic cardiomyopathy 💬	1件: ACE 💬	D08068 💬	Imidapril	1件: 67 💬
208	Diabetic cardiomyopathy 💬	1件: ACE 💬	D00362 💬	Lisinopril	7件: 19, 46, 49, 66, 67, 113, 222 💬
209	Diabetic cardiomyopathy 💬	1件: ACE 💬	D08131 💬	Lisinopril	7件: 19, 46, 49, 66, 67, 113, 222 💬
210	Diabetic cardiomyopathy 💬	1件: ACE 💬	D00421 💬	Ramipril	7件: 46, 49, 66, 67, 113, 218, 257 💬
211	Diabetic cardiomyopathy 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
212	Diabetic cardiomyopathy 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
213	Diabetic cardiomyopathy 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
214	Diabetic cardiomyopathy 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
215	Diabetic cardiomyopathy 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
216	Diabetic cardiomyopathy 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
217	Diabetic cardiomyopathy 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
218	Diabetic cardiomyopathy 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
219	Dilated cardiomyopathy 💬	1件: ADRB1 💬	D00634 💬	Bisoprolol	3件: 67, 86, 113 💬
220	Dilated cardiomyopathy 💬	1件: ADRB1 💬	D02342 💬	Bisoprolol	3件: 67, 86, 113 💬
221	Dilated cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
222	Dilated cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
223	Dilated cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
224	Dilated cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
225	Dopaminergic synapse 💬	3件: CACNA1B, CACNA1C, CACNA1D 💬	D01173 💬	Cilnidipine	1件: 67 💬
226	Dopaminergic synapse 💬	2件: CACNA1C, CACNA1D 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
227	Dopaminergic synapse 💬	2件: CACNA1C, CACNA1D 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
228	Dopaminergic synapse 💬	2件: CACNA1C, CACNA1D 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
229	EGFR tyrosine kinase inhibitor resistance 💬	3件: EGFR, ERBB2, KDR 💬	D11772 💬	Tesevatinib	1件: 67 💬
230	EGFR tyrosine kinase inhibitor resistance 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
231	EGFR tyrosine kinase inhibitor resistance 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
232	EGFR tyrosine kinase inhibitor resistance 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
233	Endocrine resistance 💬	2件: EGFR, ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
234	Endocrine resistance 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
235	Endocrine resistance 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
236	Endocrine resistance 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
237	Endocytosis 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
238	Endocytosis 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
239	Endometrial cancer 💬	2件: EGFR, ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
240	Epithelial cell signaling in Helicobacter pylori infection 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
241	Epithelial cell signaling in Helicobacter pylori infection 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
242	ErbB signaling pathway 💬	2件: ABL1, SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
243	ErbB signaling pathway 💬	2件: EGFR, ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
244	ErbB signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
245	ErbB signaling pathway 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
246	Estrogen signaling pathway 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
247	Estrogen signaling pathway 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
248	Fluid shear stress and atherosclerosis 💬	1件: KDR 💬	D11772 💬	Tesevatinib	1件: 67 💬
249	Fluid shear stress and atherosclerosis 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
250	Fluid shear stress and atherosclerosis 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
251	Fluid shear stress and atherosclerosis 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
252	Focal adhesion 💬	4件: EGFR, ERBB2, FLT4, KDR 💬	D11772 💬	Tesevatinib	1件: 67 💬
253	Focal adhesion 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
254	FoxO signaling pathway 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
255	FoxO signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
256	FoxO signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
257	GABAergic synapse 💬	5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
258	GABAergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
259	GABAergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
260	GABAergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
261	GABAergic synapse 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
262	Gap junction 💬	1件: ADRB1 💬	D00634 💬	Bisoprolol	3件: 67, 86, 113 💬
263	Gap junction 💬	1件: ADRB1 💬	D02342 💬	Bisoprolol	3件: 67, 86, 113 💬
264	Gap junction 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
265	Gap junction 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
266	Gastric acid secretion 💬	1件: SSTR2 💬	D00442 💬	Octreotide	7件: 67, 75, 84, 85, 89, 193, 227 💬
267	Gastric acid secretion 💬	1件: SSTR2 💬	D06495 💬	Octreotide	7件: 67, 75, 84, 85, 89, 193, 227 💬
268	Gastric acid secretion 💬	1件: SSTR2 💬	D10147 💬	Pasireotide	3件: 67, 74, 75 💬
269	Gastric acid secretion 💬	1件: SSTR2 💬	D07431 💬	Somatostatin	2件: 67, 78 💬
270	Gastric cancer 💬	2件: EGFR, ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
271	Gastric cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
272	Gastric cancer 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
273	Glioma 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
274	Glioma 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
275	Glioma 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
276	Glucagon signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
277	Glucagon signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
278	Glutamatergic synapse 💬	2件: CACNA1C, CACNA1D 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
279	Glutamatergic synapse 💬	2件: CACNA1C, CACNA1D 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
280	Glutamatergic synapse 💬	2件: CACNA1C, CACNA1D 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
281	Glutamatergic synapse 💬	2件: CACNA1C, CACNA1D 💬	D01173 💬	Cilnidipine	1件: 67 💬
282	Glycine, serine and threonine metabolism 💬	1件: AOC3 💬	D08044 💬	Hydralazine	1件: 67 💬
283	GnRH secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
284	GnRH secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
285	GnRH secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
286	GnRH secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
287	GnRH signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
288	GnRH signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
289	GnRH signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
290	GnRH signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
291	GnRH signaling pathway 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
292	GnRH signaling pathway 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
293	Growth hormone synthesis, secretion and action 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
294	Growth hormone synthesis, secretion and action 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
295	Growth hormone synthesis, secretion and action 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
296	Growth hormone synthesis, secretion and action 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
297	Growth hormone synthesis, secretion and action 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
298	Growth hormone synthesis, secretion and action 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
299	Growth hormone synthesis, secretion and action 💬	4件: SSTR1, SSTR2, SSTR3, SSTR5 💬	D10147 💬	Pasireotide	3件: 67, 74, 75 💬
300	Growth hormone synthesis, secretion and action 💬	4件: SSTR1, SSTR2, SSTR3, SSTR5 💬	D07431 💬	Somatostatin	2件: 67, 78 💬
301	Growth hormone synthesis, secretion and action 💬	1件: SSTR2 💬	D00442 💬	Octreotide	7件: 67, 75, 84, 85, 89, 193, 227 💬
302	Growth hormone synthesis, secretion and action 💬	1件: SSTR2 💬	D06495 💬	Octreotide	7件: 67, 75, 84, 85, 89, 193, 227 💬
303	Hepatitis B 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
304	Hepatitis C 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
305	Hepatocellular carcinoma 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
306	Hepatocellular carcinoma 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
307	Hepatocellular carcinoma 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
308	Herpes simplex virus 1 infection 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
309	Herpes simplex virus 1 infection 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
310	Herpes simplex virus 1 infection 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
311	HIF-1 signaling pathway 💬	2件: EGFR, ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
312	HIF-1 signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
313	HIF-1 signaling pathway 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
314	Human cytomegalovirus infection 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
315	Human cytomegalovirus infection 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
316	Human cytomegalovirus infection 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
317	Human cytomegalovirus infection 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
318	Human immunodeficiency virus 1 infection 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
319	Human immunodeficiency virus 1 infection 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
320	Human papillomavirus infection 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
321	Human papillomavirus infection 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
322	Human papillomavirus infection 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
323	Huntington disease 💬	1件: CACNA1B 💬	D01173 💬	Cilnidipine	1件: 67 💬
324	Huntington disease 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
325	Huntington disease 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
326	Huntington disease 💬	1件: PPARG 💬	D00945 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
327	Huntington disease 💬	1件: PPARG 💬	D08378 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
328	Hypertrophic cardiomyopathy 💬	1件: ACE 💬	D08068 💬	Imidapril	1件: 67 💬
329	Hypertrophic cardiomyopathy 💬	1件: ACE 💬	D00362 💬	Lisinopril	7件: 19, 46, 49, 66, 67, 113, 222 💬
330	Hypertrophic cardiomyopathy 💬	1件: ACE 💬	D08131 💬	Lisinopril	7件: 19, 46, 49, 66, 67, 113, 222 💬
331	Hypertrophic cardiomyopathy 💬	1件: ACE 💬	D00421 💬	Ramipril	7件: 46, 49, 66, 67, 113, 218, 257 💬
332	Hypertrophic cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
333	Hypertrophic cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
334	Hypertrophic cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
335	Hypertrophic cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
336	Hypertrophic cardiomyopathy 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
337	Hypertrophic cardiomyopathy 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
338	Inflammatory mediator regulation of TRP channels 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
339	Insulin resistance 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
340	Insulin resistance 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
341	Insulin resistance 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
342	Insulin resistance 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
343	Insulin secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
344	Insulin secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
345	Insulin secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
346	Insulin secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
347	Insulin signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
348	Insulin signaling pathway 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
349	Insulin signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
350	Insulin signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
351	JAK-STAT signaling pathway 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
352	JAK-STAT signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
353	JAK-STAT signaling pathway 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
354	Kaposi sarcoma-associated herpesvirus infection 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
355	Kaposi sarcoma-associated herpesvirus infection 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
356	Kaposi sarcoma-associated herpesvirus infection 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
357	Long-term potentiation 💬	1件: CACNA1C 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
358	Long-term potentiation 💬	1件: CACNA1C 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
359	Long-term potentiation 💬	1件: CACNA1C 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
360	Long-term potentiation 💬	1件: CACNA1C 💬	D01173 💬	Cilnidipine	1件: 67 💬
361	Longevity regulating pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
362	Longevity regulating pathway 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
363	Longevity regulating pathway 💬	1件: PPARG 💬	D00945 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
364	Longevity regulating pathway 💬	1件: PPARG 💬	D08378 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
365	Longevity regulating pathway 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
366	Longevity regulating pathway 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
367	Longevity regulating pathway - multiple species 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
368	Longevity regulating pathway - multiple species 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
369	Longevity regulating pathway - multiple species 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
370	Longevity regulating pathway - multiple species 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
371	MAPK signaling pathway 💬	5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
372	MAPK signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
373	MAPK signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
374	MAPK signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
375	MAPK signaling pathway 💬	4件: EGFR, ERBB2, FLT4, KDR 💬	D11772 💬	Tesevatinib	1件: 67 💬
376	Melanoma 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
377	Metabolic pathways 💬	1件: AOC3 💬	D08044 💬	Hydralazine	1件: 67 💬
378	Metabolic pathways 💬	1件: HMGCR 💬	D00893 💬	Pravastatin	9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
379	Metabolic pathways 💬	1件: HMGCR 💬	D08410 💬	Pravastatin	9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
380	Metabolic pathways 💬	1件: UGCG 💬	D11633 💬	Venglustat	3件: 6 , 19, 67 💬
381	MicroRNAs in cancer 💬	1件: ABL1 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
382	MicroRNAs in cancer 💬	2件: EGFR, ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
383	MicroRNAs in cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
384	MicroRNAs in cancer 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
385	Mitophagy - animal 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
386	Morphine addiction 💬	1件: CACNA1B 💬	D01173 💬	Cilnidipine	1件: 67 💬
387	mTOR signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
388	mTOR signaling pathway 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
389	mTOR signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
390	mTOR signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
391	Neuroactive ligand-receptor interaction 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	D00608 💬	Doxazosin	2件: 57, 67 💬
392	Neuroactive ligand-receptor interaction 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	D07874 💬	Doxazosin	2件: 57, 67 💬
393	Neuroactive ligand-receptor interaction 💬	1件: ADRB1 💬	D00634 💬	Bisoprolol	3件: 67, 86, 113 💬
394	Neuroactive ligand-receptor interaction 💬	1件: ADRB1 💬	D02342 💬	Bisoprolol	3件: 67, 86, 113 💬
395	Neuroactive ligand-receptor interaction 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
396	Neuroactive ligand-receptor interaction 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
397	Neuroactive ligand-receptor interaction 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
398	Neuroactive ligand-receptor interaction 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
399	Neuroactive ligand-receptor interaction 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
400	Neuroactive ligand-receptor interaction 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
401	Neuroactive ligand-receptor interaction 💬	1件: AVPR2 💬	D04752 💬	Lixivaptan	1件: 67 💬
402	Neuroactive ligand-receptor interaction 💬	1件: AVPR2 💬	D01213 💬	Tolvaptan	3件: 67, 72, 225 💬
403	Neuroactive ligand-receptor interaction 💬	5件: SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬	D07431 💬	Somatostatin	2件: 67, 78 💬
404	Neuroactive ligand-receptor interaction 💬	4件: SSTR1, SSTR2, SSTR3, SSTR5 💬	D10147 💬	Pasireotide	3件: 67, 74, 75 💬
405	Neuroactive ligand-receptor interaction 💬	1件: SSTR2 💬	D00442 💬	Octreotide	7件: 67, 75, 84, 85, 89, 193, 227 💬
406	Neuroactive ligand-receptor interaction 💬	1件: SSTR2 💬	D06495 💬	Octreotide	7件: 67, 75, 84, 85, 89, 193, 227 💬
407	Neurotrophin signaling pathway 💬	1件: ABL1 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
408	Neutrophil extracellular trap formation 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
409	Neutrophil extracellular trap formation 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
410	Neutrophil extracellular trap formation 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
411	Nicotine addiction 💬	1件: CACNA1B 💬	D01173 💬	Cilnidipine	1件: 67 💬
412	Non-alcoholic fatty liver disease 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
413	Non-alcoholic fatty liver disease 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
414	Non-small cell lung cancer 💬	2件: EGFR, ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
415	Osteoclast differentiation 💬	1件: PPARG 💬	D00945 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
416	Osteoclast differentiation 💬	1件: PPARG 💬	D08378 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
417	Oxytocin signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
418	Oxytocin signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
419	Oxytocin signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
420	Oxytocin signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
421	Oxytocin signaling pathway 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
422	Oxytocin signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
423	Oxytocin signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
424	Oxytocin signaling pathway 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
425	Pancreatic cancer 💬	2件: EGFR, ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
426	Pancreatic cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
427	Pancreatic cancer 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
428	Parathyroid hormone synthesis, secretion and action 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
429	Pathogenic Escherichia coli infection 💬	2件: ABL1, SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
430	Pathways in cancer 💬	1件: ABL1 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
431	Pathways in cancer 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
432	Pathways in cancer 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
433	Pathways in cancer 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
434	Pathways in cancer 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
435	Pathways in cancer 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
436	Pathways in cancer 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
437	Pathways in cancer 💬	3件: EGFR, ERBB2, FLT4 💬	D11772 💬	Tesevatinib	1件: 67 💬
438	Pathways in cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
439	Pathways in cancer 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
440	Pathways in cancer 💬	1件: PPARG 💬	D00945 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
441	Pathways in cancer 💬	1件: PPARG 💬	D08378 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
442	Pathways of neurodegeneration - multiple diseases 💬	5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
443	Pathways of neurodegeneration - multiple diseases 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
444	Pathways of neurodegeneration - multiple diseases 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
445	Pathways of neurodegeneration - multiple diseases 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
446	Pathways of neurodegeneration - multiple diseases 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
447	Pathways of neurodegeneration - multiple diseases 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
448	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
449	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
450	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
451	Phenylalanine metabolism 💬	1件: AOC3 💬	D08044 💬	Hydralazine	1件: 67 💬
452	Phospholipase D signaling pathway 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
453	Phospholipase D signaling pathway 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
454	Phospholipase D signaling pathway 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
455	Phospholipase D signaling pathway 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
456	Phospholipase D signaling pathway 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
457	Phospholipase D signaling pathway 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
458	Phospholipase D signaling pathway 💬	1件: AVPR2 💬	D04752 💬	Lixivaptan	1件: 67 💬
459	Phospholipase D signaling pathway 💬	1件: AVPR2 💬	D01213 💬	Tolvaptan	3件: 67, 72, 225 💬
460	Phospholipase D signaling pathway 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
461	Phospholipase D signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
462	Phospholipase D signaling pathway 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
463	PI3K-Akt signaling pathway 💬	4件: EGFR, ERBB2, FLT4, KDR 💬	D11772 💬	Tesevatinib	1件: 67 💬
464	PI3K-Akt signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
465	PI3K-Akt signaling pathway 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
466	PI3K-Akt signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
467	PI3K-Akt signaling pathway 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
468	Platelet activation 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
469	Platinum drug resistance 💬	1件: ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
470	PPAR signaling pathway 💬	1件: PPARG 💬	D00945 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
471	PPAR signaling pathway 💬	1件: PPARG 💬	D08378 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
472	Prion disease 💬	5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
473	Prion disease 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
474	Prion disease 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
475	Prion disease 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
476	Prolactin signaling pathway 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
477	Prostate cancer 💬	2件: EGFR, ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
478	Prostate cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
479	Prostate cancer 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
480	Proteoglycans in cancer 💬	3件: EGFR, ERBB2, KDR 💬	D11772 💬	Tesevatinib	1件: 67 💬
481	Proteoglycans in cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
482	Proteoglycans in cancer 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
483	Proteoglycans in cancer 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
484	Rap1 signaling pathway 💬	3件: EGFR, FLT4, KDR 💬	D11772 💬	Tesevatinib	1件: 67 💬
485	Rap1 signaling pathway 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
486	Ras signaling pathway 💬	1件: ABL1 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
487	Ras signaling pathway 💬	3件: EGFR, FLT4, KDR 💬	D11772 💬	Tesevatinib	1件: 67 💬
488	Regulation of actin cytoskeleton 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
489	Regulation of actin cytoskeleton 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
490	Regulation of lipolysis in adipocytes 💬	1件: ADRB1 💬	D00634 💬	Bisoprolol	3件: 67, 86, 113 💬
491	Regulation of lipolysis in adipocytes 💬	1件: ADRB1 💬	D02342 💬	Bisoprolol	3件: 67, 86, 113 💬
492	Relaxin signaling pathway 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
493	Relaxin signaling pathway 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
494	Renin secretion 💬	1件: ACE 💬	D08068 💬	Imidapril	1件: 67 💬
495	Renin secretion 💬	1件: ACE 💬	D00362 💬	Lisinopril	7件: 19, 46, 49, 66, 67, 113, 222 💬
496	Renin secretion 💬	1件: ACE 💬	D08131 💬	Lisinopril	7件: 19, 46, 49, 66, 67, 113, 222 💬
497	Renin secretion 💬	1件: ACE 💬	D00421 💬	Ramipril	7件: 46, 49, 66, 67, 113, 218, 257 💬
498	Renin secretion 💬	1件: ADRB1 💬	D00634 💬	Bisoprolol	3件: 67, 86, 113 💬
499	Renin secretion 💬	1件: ADRB1 💬	D02342 💬	Bisoprolol	3件: 67, 86, 113 💬
500	Renin secretion 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
501	Renin secretion 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
502	Renin secretion 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
503	Renin secretion 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
504	Renin secretion 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
505	Renin secretion 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
506	Renin secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
507	Renin secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
508	Renin secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
509	Renin secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
510	Renin-angiotensin system 💬	1件: ACE 💬	D08068 💬	Imidapril	1件: 67 💬
511	Renin-angiotensin system 💬	1件: ACE 💬	D00362 💬	Lisinopril	7件: 19, 46, 49, 66, 67, 113, 222 💬
512	Renin-angiotensin system 💬	1件: ACE 💬	D08131 💬	Lisinopril	7件: 19, 46, 49, 66, 67, 113, 222 💬
513	Renin-angiotensin system 💬	1件: ACE 💬	D00421 💬	Ramipril	7件: 46, 49, 66, 67, 113, 218, 257 💬
514	Renin-angiotensin system 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
515	Renin-angiotensin system 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
516	Renin-angiotensin system 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
517	Renin-angiotensin system 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
518	Renin-angiotensin system 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
519	Renin-angiotensin system 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
520	Retrograde endocannabinoid signaling 💬	5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
521	Retrograde endocannabinoid signaling 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
522	Retrograde endocannabinoid signaling 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
523	Retrograde endocannabinoid signaling 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
524	Salivary secretion 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	D00608 💬	Doxazosin	2件: 57, 67 💬
525	Salivary secretion 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	D07874 💬	Doxazosin	2件: 57, 67 💬
526	Salivary secretion 💬	1件: ADRB1 💬	D00634 💬	Bisoprolol	3件: 67, 86, 113 💬
527	Salivary secretion 💬	1件: ADRB1 💬	D02342 💬	Bisoprolol	3件: 67, 86, 113 💬
528	Serotonergic synapse 💬	5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
529	Serotonergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
530	Serotonergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
531	Serotonergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
532	Shigellosis 💬	1件: EGFR 💬	D11772 💬	Tesevatinib	1件: 67 💬
533	Shigellosis 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
534	Shigellosis 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
535	Shigellosis 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
536	Sphingolipid metabolism 💬	1件: UGCG 💬	D11633 💬	Venglustat	3件: 6 , 19, 67 💬
537	Spinocerebellar ataxia 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
538	Spinocerebellar ataxia 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
539	Synaptic vesicle cycle 💬	1件: CACNA1B 💬	D01173 💬	Cilnidipine	1件: 67 💬
540	Taste transduction 💬	1件: CACNA1C 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
541	Taste transduction 💬	1件: CACNA1C 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
542	Taste transduction 💬	1件: CACNA1C 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
543	Taste transduction 💬	1件: CACNA1C 💬	D01173 💬	Cilnidipine	1件: 67 💬
544	Taste transduction 💬	2件: TAS1R2, TAS1R3 💬	D02381 💬	Aspartame	5件: 6 , 13, 67, 86, 230 💬
545	Terpenoid backbone biosynthesis 💬	1件: HMGCR 💬	D00893 💬	Pravastatin	9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
546	Terpenoid backbone biosynthesis 💬	1件: HMGCR 💬	D08410 💬	Pravastatin	9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
547	Th17 cell differentiation 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
548	Th17 cell differentiation 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
549	Thermogenesis 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
550	Thermogenesis 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
551	Thermogenesis 💬	1件: PPARG 💬	D00945 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
552	Thermogenesis 💬	1件: PPARG 💬	D08378 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
553	Thermogenesis 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
554	Thermogenesis 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
555	Thyroid cancer 💬	1件: PPARG 💬	D00945 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
556	Thyroid cancer 💬	1件: PPARG 💬	D08378 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
557	Thyroid hormone signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
558	Thyroid hormone signaling pathway 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
559	Thyroid hormone signaling pathway 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
560	Tight junction 💬	1件: CACNA1D 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
561	Tight junction 💬	1件: CACNA1D 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
562	Tight junction 💬	1件: CACNA1D 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
563	Tight junction 💬	1件: CACNA1D 💬	D01173 💬	Cilnidipine	1件: 67 💬
564	Tight junction 💬	1件: ERBB2 💬	D11772 💬	Tesevatinib	1件: 67 💬
565	Tight junction 💬	2件: PRKAA1, PRKAA2 💬	D00944 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
566	Tight junction 💬	2件: PRKAA1, PRKAA2 💬	D04966 💬	Metformin	21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
567	Tight junction 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
568	Transcriptional misregulation in cancer 💬	1件: PPARG 💬	D00945 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
569	Transcriptional misregulation in cancer 💬	1件: PPARG 💬	D08378 💬	Pioglitazone	17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
570	Tuberculosis 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
571	Type II diabetes mellitus 💬	3件: CACNA1B, CACNA1C, CACNA1D 💬	D01173 💬	Cilnidipine	1件: 67 💬
572	Type II diabetes mellitus 💬	2件: CACNA1C, CACNA1D 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
573	Type II diabetes mellitus 💬	2件: CACNA1C, CACNA1D 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
574	Type II diabetes mellitus 💬	2件: CACNA1C, CACNA1D 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
575	Type II diabetes mellitus 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
576	Type II diabetes mellitus 💬	1件: MTOR 💬	D00753 💬	Sirolimus	40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
577	Tyrosine metabolism 💬	1件: AOC3 💬	D08044 💬	Hydralazine	1件: 67 💬
578	Vascular smooth muscle contraction 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	D00608 💬	Doxazosin	2件: 57, 67 💬
579	Vascular smooth muscle contraction 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	D07874 💬	Doxazosin	2件: 57, 67 💬
580	Vascular smooth muscle contraction 💬	1件: AGTR1 💬	D00522 💬	Candesartan	2件: 58, 67 💬
581	Vascular smooth muscle contraction 💬	1件: AGTR1 💬	D00522 💬	Candesartan cilexetil	1件: 67 💬
582	Vascular smooth muscle contraction 💬	1件: AGTR1 💬	D00626 💬	Candesartan cilexetil	1件: 67 💬
583	Vascular smooth muscle contraction 💬	1件: AGTR1 💬	D00357 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
584	Vascular smooth muscle contraction 💬	1件: AGTR1 💬	D08146 💬	Losartan	18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
585	Vascular smooth muscle contraction 💬	1件: AGTR1 💬	D00627 💬	Telmisartan	2件: 66, 67 💬
586	Vascular smooth muscle contraction 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00615 💬	Amlodipine	4件: 13, 51, 67, 298 💬
587	Vascular smooth muscle contraction 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02914 💬	Amlodipine	4件: 13, 51, 67, 298 💬
588	Vascular smooth muscle contraction 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D07450 💬	Amlodipine	4件: 13, 51, 67, 298 💬
589	Vascular smooth muscle contraction 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01173 💬	Cilnidipine	1件: 67 💬
590	Vasopressin-regulated water reabsorption 💬	1件: AVPR2 💬	D04752 💬	Lixivaptan	1件: 67 💬
591	Vasopressin-regulated water reabsorption 💬	1件: AVPR2 💬	D01213 💬	Tolvaptan	3件: 67, 72, 225 💬
592	VEGF signaling pathway 💬	1件: KDR 💬	D11772 💬	Tesevatinib	1件: 67 💬
593	VEGF signaling pathway 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
594	Viral carcinogenesis 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
595	Viral myocarditis 💬	1件: ABL1 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬
596	Yersinia infection 💬	1件: SRC 💬	D03252 💬	Bosutinib	2件: 2 , 67 💬

先頭へ